File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Oleanolic Acid Delivery using Biodegradable Nanoparticles for Cancer Therapy
Title | Oleanolic Acid Delivery using Biodegradable Nanoparticles for Cancer Therapy |
---|---|
Authors | |
Issue Date | 2014 |
Citation | The 2014 International Colloid and Interface Science Symposium (UK Colloids 2014), London, UK., 6-9 July 2014. In Conference Booklet, 2014, p. 267, abstract no. P45 How to Cite? |
Abstract | Oleanolic acid (OA) is a naturally occurring pentacyclic triterpenoid
widely found in Chinese herbs. It has been extensively studied owing
to the beneficial effects such as hepatoprotection, anti-inflammatory
and it is recently found to have anti-tumor ability. However,
resembling the other hydrophobic drugs, it has poor water solubility
and therefore very limited intestinal absorption when administrated
orally. Investigations concerning the delivery of OA have been
carried out to enhance its dissolution and bioavailability.
Nanoparticulate systems involve the reduction of drug particle size
into nano-scale thereby increasing the interfacial surface area. As a
result, absorption of drug in the body system could be enhanced.
Biodegradable polymer-based system can be metabolized by the
body system into harmless compounds so it is regarded safe and
promising. This study was conducted to evaluate the efficacy of four
types of biodegradable copolymers as potential OA delivery
nanoparticulate system.
Co-polymers consisting a hydrophilic block: poly(ethylene) glycol
(PEG) and a hydrophobic block of either poly(lactic-co-glycolic) acid
(PLGA) or poly(lactic acid) (PLA) were used to fabricate a novel
nanoformulation to improve OA bioavailability. The OA-loaded
mPEG-(D,L)PLA, mPEG-(L)PLA, mPEG-(D,L)PLGA and mPEG-
(L)PLGA nanoparticles (NPs), prepared by nanoprecipitation, were
observed to be spherical in shape under transmission electron
microscope. Results indicated that narrow size distributed NPs with
mean hydrodynamic diameter of 200±16.0, 233±13.9, 211±10.1 and
229±10.1nm respectively were obtained. mPEG-(D,L)PLA NPs
attained the highest encapsulation of OA with 75.8% efficiency while
mPEG-(L)PLGA NPs displayed the lowest encapsulation efficiency
at 40.8%. The in vitro anti-tumoral activity was evaluated on A549,
lung carcinoma epithelial cell lines using MTT assay. All the four
types of OA-loaded NPs demonstrated better anti-cancer ability than
saturated OA in medium. Moreover, NPs without OA exhibited
significantly lower cytotoxicity towards A549 indicating induced cell
death was due to the effective delivery of OA as an anti-cancer
therapeutic agent. |
Description | Poster Presentation |
Persistent Identifier | http://hdl.handle.net/10722/201346 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Man, KWD | en_US |
dc.contributor.author | Kwok, PCL | en_US |
dc.contributor.author | Lam, JKW | en_US |
dc.date.accessioned | 2014-08-21T07:24:50Z | - |
dc.date.available | 2014-08-21T07:24:50Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | The 2014 International Colloid and Interface Science Symposium (UK Colloids 2014), London, UK., 6-9 July 2014. In Conference Booklet, 2014, p. 267, abstract no. P45 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/201346 | - |
dc.description | Poster Presentation | - |
dc.description.abstract | Oleanolic acid (OA) is a naturally occurring pentacyclic triterpenoid widely found in Chinese herbs. It has been extensively studied owing to the beneficial effects such as hepatoprotection, anti-inflammatory and it is recently found to have anti-tumor ability. However, resembling the other hydrophobic drugs, it has poor water solubility and therefore very limited intestinal absorption when administrated orally. Investigations concerning the delivery of OA have been carried out to enhance its dissolution and bioavailability. Nanoparticulate systems involve the reduction of drug particle size into nano-scale thereby increasing the interfacial surface area. As a result, absorption of drug in the body system could be enhanced. Biodegradable polymer-based system can be metabolized by the body system into harmless compounds so it is regarded safe and promising. This study was conducted to evaluate the efficacy of four types of biodegradable copolymers as potential OA delivery nanoparticulate system. Co-polymers consisting a hydrophilic block: poly(ethylene) glycol (PEG) and a hydrophobic block of either poly(lactic-co-glycolic) acid (PLGA) or poly(lactic acid) (PLA) were used to fabricate a novel nanoformulation to improve OA bioavailability. The OA-loaded mPEG-(D,L)PLA, mPEG-(L)PLA, mPEG-(D,L)PLGA and mPEG- (L)PLGA nanoparticles (NPs), prepared by nanoprecipitation, were observed to be spherical in shape under transmission electron microscope. Results indicated that narrow size distributed NPs with mean hydrodynamic diameter of 200±16.0, 233±13.9, 211±10.1 and 229±10.1nm respectively were obtained. mPEG-(D,L)PLA NPs attained the highest encapsulation of OA with 75.8% efficiency while mPEG-(L)PLGA NPs displayed the lowest encapsulation efficiency at 40.8%. The in vitro anti-tumoral activity was evaluated on A549, lung carcinoma epithelial cell lines using MTT assay. All the four types of OA-loaded NPs demonstrated better anti-cancer ability than saturated OA in medium. Moreover, NPs without OA exhibited significantly lower cytotoxicity towards A549 indicating induced cell death was due to the effective delivery of OA as an anti-cancer therapeutic agent. | - |
dc.language | eng | en_US |
dc.relation.ispartof | International Colloid and Interface Science Symposium, UK Colloids 2014 | en_US |
dc.title | Oleanolic Acid Delivery using Biodegradable Nanoparticles for Cancer Therapy | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Kwok, PCL: pclkwok@hku.hk | en_US |
dc.identifier.email | Lam, JKW: jkwlam@hku.hk | en_US |
dc.identifier.authority | Kwok, PCL=rp01540 | en_US |
dc.identifier.authority | Lam, JKW=rp01346 | en_US |
dc.description.nature | published_or_final_version | - |
dc.identifier.hkuros | 233297 | en_US |
dc.identifier.hkuros | 238795 | - |
dc.identifier.spage | 267, abstract no. P45 | - |
dc.identifier.epage | 267, abstract no. P45 | - |